Dianthus Therapeutics | MGTA - Interest Income

Stock Price
83.57
Daily Change
-3.59 -4.12%
Monthly
5.19%
Yearly
284.23%
Q2 Forecast
85.52

Dianthus Therapeutics reported $3.66M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Celltrion KRW 676.66M 6.85B Jun/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
IQVIA Holdings USD 11M 2M Dec/2025
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Moderna USD 73M 8M Sep/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Revvity USD 0.4 8.34M Sep/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025